triazoles has been researched along with thromboxane b2 in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.85) | 18.7374 |
1990's | 22 (84.62) | 18.2507 |
2000's | 3 (11.54) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giessler, C; Mentz, G; Mentz, P; Mest, HJ | 1 |
Esser, KM; Feuerstein, G; Hillegas, LM; Rabinovici, R; Renz, JF; Sofronski, MD; Vernick, J | 1 |
Zhang, JN | 1 |
Bergmann, R; Brecht, HM; Gokel, M; Hammer, C; Saumweber, DM; Zellner, C | 1 |
Brecht, HM; Helmchen, UM; Oberle, G; Schoeppe, W; Stahl, RA; Thaiss, F; Wenzel, U | 1 |
Peskar, BA; Pritze, S; Simmet, T | 1 |
Becker, K; Förster, W; Lueddeckens, G; Rappold, R | 1 |
Fenton, J; Gudewicz, PW; Kaplan, JE; Moon, DG; van der Zee, H | 1 |
Bergmann, R; Brecht, HM; Gokel, M; Hammer, C; Saumweber, DM | 1 |
Chang, S; Czartalomna, J; Feddersen, CO; Voelkel, NF | 1 |
Geissler, FT; Henderson, WR; Kuzan, FB | 1 |
Barnes, PJ; Giembycz, MA; Kroegel, C | 1 |
Karasawa, A; Lefer, AM; Rochester, JA | 1 |
Desquand, S; Dumarey, C; Lefort, J; Vargaftig, BB | 1 |
Farhat, M; Feuerstein, G; Perera, PY; Rabinovici, R; Vogel, SN; Yue, TL | 1 |
Feuerstein, G; Rabinovici, R; Rudolph, AS; Yue, TL | 1 |
Lefort, J; Malanchère, E; Pretolani, M; Vargaftig, BB | 1 |
Duncker, HP; Heller, A; Koch, T; Neuhof, H; Schaible, R; van Ackern, K | 1 |
Chandel, B; Deshpande, Y; Kaminski, DL; Kulkarni, A; Longo, WE; Niehoff, M; Polities, G; Vernava, AM | 1 |
Johnson, LW; Kruse-Elliott, KT; Olson, NC | 1 |
Arakawa, H; Kawikova, I; Löfdahl, CG; Lötvall, J; Petersson, M; Skoogh, BE | 1 |
Alper, CM; Burckart, GJ; Diven, WF; Doyle, WJ; Evans, RW; Jaffe, R | 1 |
de la Cruz, JP; García-Campos, J; Moreno, A; Ruiz-Ruiz, MI; Sánchez de la Cuesta, F | 1 |
Fujimura, A; Kawaguchi, A; Sugimoto, K | 1 |
Hynninen, VV; Laine, K; Neuvonen, PJ; Olkkola, KT | 1 |
Bertilsson, L; Hynninen, VV; Korhonen, T; Kurkinen, KJ; Laine, K; Neuvonen, PJ; Olkkola, KT | 1 |
2 trial(s) available for triazoles and thromboxane b2
Article | Year |
---|---|
Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Biotransformation; Cross-Over Studies; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Etoricoxib; Gels; Humans; Male; Miconazole; Pyridines; Pyrimidines; Sulfones; Thromboxane B2; Triazoles; Voriconazole; Young Adult | 2009 |
Voriconazole increases while itraconazole decreases plasma meloxicam concentrations.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Blood Coagulation; Cross-Over Studies; Cyclooxygenase 1; Cytochrome P-450 Enzyme System; Drug Interactions; Genotype; Half-Life; Humans; Itraconazole; Male; Meloxicam; Protein Binding; Pyrimidines; Thiazines; Thiazoles; Thromboxane B2; Triazoles; Voriconazole; Young Adult | 2009 |
24 other study(ies) available for triazoles and thromboxane b2
Article | Year |
---|---|
Interactions of prostanoids with the platelet activating factors.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Guinea Pigs; Heart; Iloprost; In Vitro Techniques; Indomethacin; Myocardial Contraction; Perfusion; Platelet Activating Factor; Prostaglandins; Sulfonamides; Thromboxane A2; Thromboxane B2; Triazoles | 1992 |
Platelet activating factor mediates interleukin-2-induced lung injury in the rat.
Topics: Animals; Azepines; Blood Pressure; Interleukin-2; Leukocyte Count; Lung Diseases; Male; Peroxidase; Platelet Activating Factor; Platelet Count; Rats; Rats, Inbred Strains; Thromboxane B2; Triazoles; Tumor Necrosis Factor-alpha | 1992 |
[Interference of platelet-activating factor antagonist, BN50739 with the releasing of inflammatory mediators from anaphylactic lung of guinea pig].
Topics: Alveolitis, Extrinsic Allergic; Animals; Azepines; Female; Guinea Pigs; Histamine; Lung; Male; Ovalbumin; Platelet Activating Factor; Prostaglandins F; SRS-A; Thromboxane B2; Triazoles | 1992 |
Studies on xenograft rejection: the role of leukocytes and prostaglandins and their modulation by the hetrazepine WEB 2086BS.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Erythrocyte Count; Graft Rejection; Hemagglutinins; Hemoperfusion; Humans; Kidney Transplantation; Leukocytes; Platelet Activating Factor; Swine; Thromboxane B2; Transplantation, Heterologous; Triazoles | 1992 |
The platelet activating factor receptor antagonist WEB 2170 improves glomerular hemodynamics and morphology in a proliferative model of mesangial cell injury.
Topics: Animals; Antilymphocyte Serum; Azepines; Dinoprostone; Disease Models, Animal; Glomerular Filtration Rate; Glomerular Mesangium; Glomerulonephritis; Inulin; Male; Platelet Membrane Glycoproteins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane B2; Triazoles | 1991 |
Effect of platelet-activating factor on porcine pulmonary blood vessels in vitro.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Calcimycin; Diterpenes; Eicosanoids; Ginkgolides; In Vitro Techniques; Lactones; Male; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pulmonary Circulation; Radioimmunoassay; SRS-A; Swine; Thromboxane B2; Triazoles | 1991 |
Influence of aminophylline and ketotifen in comparison to the lipoxygenase inhibitors NDGA and esculetin and the PAF antagonists WEB 2170 [correction of 2107] and BN 52021 on endothelin-1 induced vaso- and bronchoconstriction.
Topics: Aminophylline; Animals; Azepines; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Bronchoconstrictor Agents; Diterpenes; Endothelins; Ginkgolides; Guinea Pigs; Ketotifen; Lactones; Lipoxygenase Inhibitors; Lung; Male; Masoprocol; Platelet Activating Factor; Platelet Aggregation Inhibitors; Theophylline; Thromboxane B2; Triazoles; Umbelliferones; Vasoconstriction; Vasoconstrictor Agents | 1991 |
Thrombin-induced leukopenia and thrombocytopenia are attenuated by PAF antagonist WEB 2086.
Topics: Animals; Azepines; Carbon Dioxide; Cell Adhesion; Leukocyte Count; Leukopenia; Platelet Activating Factor; Sheep; Thrombin; Thrombocytopenia; Thromboxane B2; Triazoles | 1991 |
The involvement of platelet-activating factor in hyperacute xenogeneic rejection and its modulation by the PAF-antagonist WEB 2086BS.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Animals; Azepines; Female; Graft Rejection; Hemoperfusion; Humans; Kidney Transplantation; Male; Platelet Activating Factor; Swine; Thromboxane B2; Transplantation, Heterologous; Triazoles | 1991 |
Arachidonic acid causes cyclooxygenase-dependent and -independent pulmonary vasodilation.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Hypoxia; In Vitro Techniques; Male; Perfusion; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Rats; Rats, Inbred Strains; Thromboxane B2; Triazoles; Vasodilation | 1990 |
Role of spermatozoal platelet-activating factor in fertilization.
Topics: Animals; Arachidonic Acids; Azepines; Chromatography, High Pressure Liquid; Female; Fertilization; Fertilization in Vitro; Humans; Leukotriene B4; Lipoxygenase; Male; Mice; Platelet Activating Factor; Pregnancy; Prostaglandins F; Sperm Motility; Spermatozoa; Thromboxane B2; Triazines; Triazoles | 1990 |
Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
Topics: Animals; Azepines; Calcimycin; Calcium; Complement C5a; Cyclooxygenase Inhibitors; Enzyme Activation; Eosinophils; Flurbiprofen; Guinea Pigs; Imidazoles; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Superoxides; Tetradecanoylphorbol Acetate; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Triazines; Triazoles | 1990 |
Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
Topics: Animals; Azepines; Blood Pressure; Cathepsin D; In Vitro Techniques; Male; Myocardial Depressant Factor; Nitrogen; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rabbits; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Traumatic; Thromboxane B2; Triazoles | 1990 |
The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086.
Topics: Anaphylaxis; Animals; Azepines; Blood Cell Count; Bronchi; Enzyme-Linked Immunosorbent Assay; Guinea Pigs; Histamine; Immunization, Secondary; Immunoglobulin G; Lung; Ovalbumin; Platelet Activating Factor; Radioimmunoassay; Spectrometry, Fluorescence; Thromboxane B2; Triazoles | 1990 |
Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits.
Topics: Animals; Azepines; Blood Cell Count; Endotoxins; Leukopenia; Male; Platelet Activating Factor; Rabbits; Thrombocytopenia; Thromboxane B2; Triazoles | 1990 |
Biological responses to liposome-encapsulated hemoglobin (LEH) are improved by a PAF antagonist.
Topics: Animals; Azepines; Blood Substitutes; Chemical Phenomena; Chemistry, Physical; Drug Interactions; Hemodynamics; Hemoglobins; Leukocyte Count; Liposomes; Male; Oxygen; Phosphatidylcholines; Platelet Activating Factor; Platelet Count; Rats; Rats, Inbred Strains; Thromboxane B2; Triazoles | 1990 |
Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
Topics: Anaphylaxis; Animals; Azepines; Female; Guinea Pigs; Histamine; In Vitro Techniques; Indicators and Reagents; Leukopenia; Male; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Radioimmunoassay; Respiratory System; Spectrometry, Fluorescence; Thrombocytopenia; Thromboxane B2; Triazines; Triazoles | 1987 |
Effects of stroma-free hemoglobin solutions on pulmonary vascular resistance and mediator release in the isolated perfused rabbit lung.
Topics: Animals; Azepines; Catalase; Cattle; Deferoxamine; Diclofenac; Female; Free Radical Scavengers; Hemoglobins; Histamine Release; Iron; Male; Perfusion; Platelet Activating Factor; Pulmonary Circulation; Rabbits; Stimulation, Chemical; Thromboxane B2; Triazoles; Vascular Resistance; Vasoconstriction | 1994 |
Platelet-activating factor mediates trinitrobenzene induced colitis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Colitis; Colon; Dinoprostone; Eicosanoids; Gastrointestinal Contents; Leukotriene B4; Platelet Activating Factor; Rabbits; Second Messenger Systems; Thromboxane B2; Triazoles; Trinitrobenzenesulfonic Acid | 1994 |
Effect of 5-lipoxygenase and cyclooxygenase blockade on porcine hemodynamics during continuous infusion of platelet-activating factor.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Blood; Calcimycin; Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Hemodynamics; Hypertension, Pulmonary; In Vitro Techniques; Indomethacin; Infusions, Intra-Arterial; Leukotriene B4; Lipoxygenase Inhibitors; Naphthoquinones; ortho-Aminobenzoates; Platelet Activating Factor; Swine; Thromboxane B2; Triazoles | 1993 |
Bradykinin-induced release of thromboxane B2 into bronchoalveolar lavage fluid of guinea pigs: relationship to airflow obstruction.
Topics: Airway Obstruction; Animals; Azepines; Bradykinin; Bronchoalveolar Lavage Fluid; Dioxanes; Guinea Pigs; Injections, Spinal; Male; Methacrylates; Neuromuscular Depolarizing Agents; Platelet Aggregation Inhibitors; Propranolol; Radioimmunoassay; Succinylcholine; Thromboxane B2; Thromboxane-A Synthase; Trachea; Triazoles; Vasodilator Agents | 1995 |
Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Animals; Azepines; Biphenyl Compounds; Chinchilla; Dinoprostone; Ear, Middle; Fatty Acids, Nonesterified; Heptanoic Acids; Hydrolases; Leukotriene Antagonists; Leukotriene C4; Mucous Membrane; Otitis Media; Phospholipids; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pneumococcal Infections; Propionates; Quinolines; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Thromboxane; Thromboxane B2; Triazoles | 1998 |
Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.
Topics: Analysis of Variance; Animals; Azepines; Blood Glucose; Blood Platelets; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dose-Response Relationship, Drug; Epoprostenol; Lipid Peroxidation; Male; Neovascularization, Pathologic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Retina; Thromboxane B2; Triazoles | 1998 |
Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephrotoxicity.
Topics: Animals; Azepines; Cyclosporine; Dose-Response Relationship, Drug; Endothelin-1; Hemodynamics; Immunosuppressive Agents; Kidney; Male; Platelet Activating Factor; Rats; Rats, Wistar; Thromboxane B2; Triazoles | 2001 |